SMV
Sofinnova Management VIII Portfolio holdings
AUM
$183M
This Quarter Return
-17.21%
1 Year Return
+2.31%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$183M
AUM Growth
+$183M
(+12%)
Cap. Flow
+$50.2M
Cap. Flow
% of AUM
27.4%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
2
Reduced
–
Closed
–
Top Buys
| 1 |
NCNA
NuCana
NCNA
|
$40.4M |
| 2 |
OBSV
ObsEva SA Ordinary Shares
OBSV
|
$9.76M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 86.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NCNA
1
NuCana
NCNA
$5.76M
| $47.2M | 25.76% |
4,666,666
+4,000,000
| +600% | +$40.4M |
|
|
OBSV
2
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $46.4M | 25.31% |
4,749,623
+1,000,000
| +27% | +$9.76M |
|
3
Aclaris Therapeutics
ACRS
$219M
| $38M | 20.72% |
1,539,480
| – | – |
|
|
ONCE
4
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $24.7M | 13.51% |
481,270
| – | – |
|
5
Natera
NTRA
$23.3B
| $13.9M | 7.61% |
1,550,280
| – | – |
|
|
CYTO
6
DELISTED
Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda)
CYTO
| $4.62M | 2.52% |
7,818,175
| – | – |
|
7
Ocugen
OCGN
$319M
| $4.26M | 2.32% |
2,077,040
| – | – |
|
8
Synlogic
SYBX
$17.2M
| $4.12M | 2.25% |
424,972
| – | – |
|